SecurityAMD / Advanced Micro Devices, Inc. (007903107)
President & CEOSu Lisa T
Form 4 Count449
Form 8-K Count97
Form 10-Q Count20
Form 3 Count15

SEC Filings - 10K, 8K, Annual Reports

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Advanced Micro Devices, Inc.


DateFormTitle
2018-08-06 8-K AMD / Advanced Micro Devices, Inc. 8-K (Current Report)
2018-08-02 SC 13D/A AMD / Advanced Micro Devices, Inc. / Mubadala Investment Co Pjsc - AMENDMENT NO. 10 (Activist Investment)
2018-08-02 SC 13D/A AMD / Advanced Micro Devices, Inc. / Mubadala Investment Co Pjsc - AMENDMENT NO. 10 (Activist Investment)
2018-08-02 10-Q AMD / Advanced Micro Devices, Inc. 10-Q (Quarterly Report)
2018-07-31 144 AMD / Advanced Micro Devices, Inc. FILING FOR PROPOSED SALE OF SECURITIES
2018-07-31 144 AMD / Advanced Micro Devices, Inc. FILING FOR PROPOSED SALE OF SECURITIES
2018-07-25 8-K AMD / Advanced Micro Devices, Inc. 8-K (Current Report)
2018-07-02 8-K AMD / Advanced Micro Devices, Inc. 8-K (Current Report)
2018-05-27 SD AMD / Advanced Micro Devices, Inc. SD
2018-05-08 8-K AMD / Advanced Micro Devices, Inc. 8-K (Current Report)
2018-05-03 10-Q AMD / Advanced Micro Devices, Inc. 10-Q (Quarterly Report)
2018-04-25 8-K AMD / Advanced Micro Devices, Inc. 8-K (Current Report)
2018-03-19 DEFA14A AMD / Advanced Micro Devices, Inc. DEFA14A
2018-03-19 DEF 14A AMD / Advanced Micro Devices, Inc. DEF 14A
2018-03-06 PRE 14A AMD / Advanced Micro Devices, Inc. PRE 14A
2018-03-05 8-K AMD / Advanced Micro Devices, Inc. 8-K (Current Report)
2018-02-27 8-K AMD / Advanced Micro Devices, Inc. 8-K (Current Report)
2018-02-27 10-K AMD / Advanced Micro Devices, Inc. 10-K (Annual Report)
2018-02-12 8-K AMD / Advanced Micro Devices, Inc. 8-K NEO 2017 EIP (Current Report)
2018-02-08 SC 13G/A AMD / Advanced Micro Devices, Inc. / BlackRock Inc. - 3G/A (Passive Investment)
2018-02-08 SC 13G/A AMD / Advanced Micro Devices, Inc. / BlackRock Inc. - 3G/A (Passive Investment)
2018-01-30 8-K AMD / Advanced Micro Devices, Inc. 8-K (Current Report)
2018-01-10 SC 13G/A AMD / Advanced Micro Devices, Inc. / VANGUARD GROUP INC - 3G/A (Passive Investment)
2018-01-10 SC 13G/A AMD / Advanced Micro Devices, Inc. / VANGUARD GROUP INC - 3G/A (Passive Investment)
2017-11-02 10-Q Advanced Micro Devices 10-Q (Quarterly Report)
2017-11-01 8-K Advanced Micro Devices 8-K (Current Report/Significant Event)
2017-10-24 8-K Advanced Micro Devices 8-K (Current Report/Significant Event)
2017-08-07 8-K Advanced Micro Devices 8-K (Current Report/Significant Event)
2017-08-18 144 Advanced Micro Devices FORM 144
2017-08-04 SC 13D/A Advanced Micro Devices AMENDMENT NO. 9 TO SCHEDULE 13D (Activist Acquisition of More Than 5% of Shares)
2017-08-18 144 Advanced Micro Devices FORM 144
2017-08-04 SC 13D/A Advanced Micro Devices AMENDMENT NO. 9 TO SCHEDULE 13D (Activist Acquisition of More Than 5% of Shares)
2017-08-03 10-Q Advanced Micro Devices 10-Q (Quarterly Report)
2017-07-25 8-K Advanced Micro Devices 8-K (Current Report/Significant Event)
2017-07-05 SC 13D/A Advanced Micro Devices AMENDMENT NO. 8 TO SCHEDULE 13D (Activist Acquisition of More Than 5% of Shares)
2017-07-05 SC 13D/A Advanced Micro Devices AMENDMENT NO. 8 TO SCHEDULE 13D (Activist Acquisition of More Than 5% of Shares)
2017-07-03 8-K Advanced Micro Devices 8-K (Current Report/Significant Event)
2017-05-30 SD Advanced Micro Devices SD
2017-05-08 S-8 Advanced Micro Devices S-8
2017-05-08 10-Q Advanced Micro Devices 10-Q (Quarterly Report)
2017-05-01 8-K Advanced Micro Devices 8-K (Current Report/Significant Event)
2017-04-28 8-K Advanced Micro Devices FORM 8-K (Current Report/Significant Event)
2017-03-22 8-K Advanced Micro Devices 8-K (Current Report/Significant Event)
2017-03-13 8-K/A Advanced Micro Devices 8-K/A (Current Report/Significant Event)
2017-03-08 DEFA14A Advanced Micro Devices DEFA14A
2017-03-08 DEF 14A Advanced Micro Devices DEF 14A
2017-03-06 SC 13D/A Advanced Micro Devices AMENDMENT NO. 7 (Activist Acquisition of More Than 5% of Shares)
2017-03-06 SC 13D/A Advanced Micro Devices AMENDMENT NO. 7 (Activist Acquisition of More Than 5% of Shares)
2017-03-03 144 Advanced Micro Devices FORM 144
2017-03-02 8-K Advanced Micro Devices 8-K (Current Report/Significant Event)
AMD: Advanced Micro Devices Stock Analysis and Research Report

2017-09-28 - Asif

We are a global semiconductor company with facilities around the world. Within the global semiconductor industry, we offer primarily: x86 microprocessors, as standalone devices or as incorporated as an accelerated processing unit (APU), chipsets, discrete graphics processing units (GPUs) and professional graphics processors; and server and embedded processors, semi-custom System-on-Chip (SoC) products and technology for game consoles. We also license portions of our intellectual property portfolio. In this section, we will describe the general financial condition and the results of operations of Advanced Micro Devices, Inc. and its wholly-owned subsidiaries (collectively, “us,” “our” or “AMD”), including a discussion of our results of operations for the quarter and six months ended July 1, 2017 compared to the quarter and six months ended June 25, 2016 , an analysis of changes in our financial condition and a discussion of our contractual obligations. We believe our fin...

Related Articles

REPH: Recro Pharma Analysis and Research Report

2018-08-20 - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

2018-08-20 - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...

Silicon Investor Message Boards

This table lists all message boards related to AMD / Advanced Micro Devices, Inc. on message board site Silicon Investor.

AMD, ARMH, INTC, NVDA AMD, ARMH, INTC, NVDA AMD, ARMH, INTC, NVDA Advanced Micro Devices - Moderated (AMD) Advanced Micro Devices - Moderated (AMD) Advanced Micro Devices - Moderated (AMD)
DOX: Amdocs Limited DOX: Amdocs Limited DOX: Amdocs Limited Advanced Micro vs Intel (AMD / INTC) Advanced Micro vs Intel (AMD / INTC) Advanced Micro vs Intel (AMD / INTC)
AMD ATI INTC NVDA Moderated AMD ATI INTC NVDA Moderated AMD ATI INTC NVDA Moderated MCAMD Motorcyles Centers of America /EUniverse.com MCAMD Motorcyles Centers of America /EUniverse.com MCAMD Motorcyles Centers of America /EUniverse.com
Ameridex Minerals Corp (AMD was NRV) Ameridex Minerals Corp (AMD was NRV) Ameridex Minerals Corp (AMD was NRV) Advanced Micro Devices - Off Topic Advanced Micro Devices - Off Topic Advanced Micro Devices - Off Topic
AMD K6 versus Cyrix M2 AMD K6 versus Cyrix M2 AMD K6 versus Cyrix M2 AMD:News, Press Releases and Information Only! AMD:News, Press Releases and Information Only! AMD:News, Press Releases and Information Only!
CUSIP: 007903107